No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3)
- PMID: 29617726
- PMCID: PMC6005063
- DOI: 10.1093/annonc/mdy104
No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3)
Abstract
Background: There is observational evidence suggesting that high vitamin D concentrations may protect against lung cancer. To investigate this hypothesis in detail, we measured circulating vitamin D concentrations in prediagnostic blood from 20 cohorts participating in the Lung Cancer Cohort Consortium (LC3).
Patients and methods: The study included 5313 lung cancer cases and 5313 controls. Blood samples for the cases were collected, on average, 5 years before lung cancer diagnosis. Controls were individually matched to the cases by cohort, sex, age, race/ethnicity, date of blood collection, and smoking status in five categories. Liquid chromatography coupled with tandem mass spectrometry was used to separately analyze 25-hydroxyvitamin D2 [25(OH)D2] and 25-hydroxyvitamin D3 [25(OH)D3] and their concentrations were combined to give an overall measure of 25(OH)D. We used conditional logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for 25(OH)D as both continuous and categorical variables.
Results: Overall, no apparent association between 25(OH)D and risk of lung cancer was observed (multivariable adjusted OR for a doubling in concentration: 0.98, 95% CI: 0.91, 1.06). Similarly, we found no clear evidence of interaction by cohort, sex, age, smoking status, or histology.
Conclusion: This study did not support an association between vitamin D concentrations and lung cancer risk.
Figures




References
-
- Ferlay J, Soerjomataram I, Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5): E359–E386. - PubMed
-
- Zhang L, Wang S, Che X, Li X.. Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cell Physiol Biochem 2015; 36(1): 299–305. - PubMed
-
- Chen G-C, Zhang Z-L, Wan Z. et al. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis. Cancer Causes Control 2015; 26(12): 1719–1728. - PubMed
-
- Feldman D, Krishnan AV, Swami S. et al. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 2014; 14(5): 342–357. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201600002C/HL/NHLBI NIH HHS/United States
- R01 CA082729/CA/NCI NIH HHS/United States
- R37 CA070867/CA/NCI NIH HHS/United States
- UM1 CA173640/CA/NCI NIH HHS/United States
- HHSN268201600003C/HL/NHLBI NIH HHS/United States
- HHSN268201600004C/HL/NHLBI NIH HHS/United States
- HHSN268201600001C/HL/NHLBI NIH HHS/United States
- UM1 CA182910/CA/NCI NIH HHS/United States
- 001/WHO_/World Health Organization/International
- U01 CA155340/CA/NCI NIH HHS/United States
- R01 HL102122/HL/NHLBI NIH HHS/United States
- HHSN268201600018C/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical